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Intracellular trafficking of retroviral RNAs is a potential mechanism to target viral gene expression to
specific regions of infected cells. Here we show that the human immunodeficiency virus type 1 (HIV-1) genome
contains two sequences similar to the hnRNP A2 response element (A2RE), a cis-acting RNA trafficking
sequence that binds to the trans-acting trafficking factor, hnRNP A2, and mediates a specific RNA trafficking
pathway characterized extensively in oligodendrocytes. The two HIV-1 sequences, designated A2RE-1, within
the major homology region of the gag gene, and A2RE-2, in a region of overlap between the vpr and tat genes,
both bind to hnRNP A2 in vitro and are necessary and sufficient for RNA transport in oligodendrocytes in vivo.
A single base change (A8G) in either sequence reduces hnRNP A2 binding and, in the case of A2RE-2, inhibits
RNA transport. A2RE-mediated RNA transport is microtubule and hnRNP A2 dependent. Differentially
labelled gag and vpr RNAs, containing A2RE-1 and A2RE-2, respectively, coassemble into the same RNA
trafficking granules and are cotransported to the periphery of the cell. tat RNA, although it contains A2RE-2,
is not transported as efficiently as vpr RNA. An A2RE/hnRNP A2-mediated trafficking pathway for HIV RNA
is proposed, and the role of RNA trafficking in targeting HIV gene expression is discussed.
Many eucaryotic RNAs have characteristic intracellular traf-
ficking pathways determined by cis-acting elements in the
RNA and trans-acting factors in the cell. cis and trans traffick-
ing determinants have been identified for actin mRNA in fi-
broblasts (38), Vg1 mRNA in frog oocytes (17) and myelin
basic protein (MBP) mRNA in oligodendrocytes (11). In the
case of MBP mRNA, a 21-nucleotide (nt) cis-acting sequence
(GCCAAGGAGCCAGAGAGCATG) mediates RNA traf-
ficking. This sequence, originally termed the RNA trafficking
sequence (2), is now referred to as the hnRNP A2 response
element (A2RE) because in binds to the trans-acting factor
hnRNP A2 in vitro (21), because its RNA trafficking functions
are hnRNP A2 dependent (23), and because A2RE mutations
that interfere with hnRNP A2 binding abolish RNA trafficking
(31).
A2RE and/or hnRNP A2 determinants have been impli-
cated at several different steps in RNA trafficking. In the nu-
cleus, hnRNP A2 associates nonspecifically with newly synthe-
sized RNA transcripts as part of the core hnRNP complex (18)
and specifically regulates splice site selection in certain tran-
scripts (29). In Drosophila melanogaster, an hnRNP A2 ortho-
logue, Squid protein, associates with pair-rule transcripts in the
nucleus and mediates their subsequent apical localization in
the cytoplasm (24). In the silkmoth Chironomus, hnRNP A2
class proteins accompany Balbiani ring mRNA during export
through the nuclear pore and into polyribosomes (14, 15, 43).
In oligodendrocytes, hnRNP A2 mediates anterograde trans-
port of A2RE-containing RNA granules (6) along microtu-
bules (2, 11), and translation of A2RE-containing RNA is
enhanced by hnRNP A2 in vivo and in vitro (23). Since A2RE-
like sequences are found in a variety of transported mRNAs
(2) and since hnRNP A2 is constitutively expressed in most cell
types (22), the A2RE/hnRNP A2 pathway may represent a
general RNA trafficking pathway.
Intracellular trafficking of retroviral RNAs is important for
viral replication (20). All retroviruses produce a single primary
transcript that is processed into various species of mRNA. In
the simpler retroviruses, usually only two species of mRNA are
made, a singly spliced RNA encoding the envelope protein and
an unspliced RNA that functions both as mRNA encoding the
Gag and Gag-Pol proteins and as genomic RNA packaged into
virions. In more complex retroviruses, such as the human im-
munodeficiency virus (HIV), processing of the primary tran-
script is more complicated, generating multiple singly spliced,
doubly spliced, or unspliced RNAs. Retroviruses utilize spe-
cific mechanisms to allow nuclear export of unspliced and
incompletely spliced mRNAs which would otherwise remain in
the nucleus since they contain introns (13, 26). In HIV-infected
cells, nuclear export of unspliced and singly spliced HIV type
1 (HIV-1) transcripts is mediated by the Rev response element
(RRE), a cis-acting sequence in the env gene (28), recognized
by the trans-acting viral Rev protein (36). Simpler retroviruses
rely on cis-acting RNA signals termed constitutive transport
elements (8, 33, 44) that interact directly with cellular proteins
to mediate export of intron-containing mRNA (7, 27).
While intranuclear processing and nuclear export of retro-
viral RNAs have been studied extensively, cytoplasmic traffick-
ing of retroviral RNA is less well understood. In the context of
a retrovirus-infected cell, cytoplasmic RNA trafficking could
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target specific RNAs to discrete subcellular locations, thereby
maximizing expression of the encoded proteins at the target
location and minimizing ectopic expression elsewhere in the
cell. Such a process could, in principle, facilitate viral assembly
by steering viral genomic RNA and mRNAs encoding viral
structural proteins toward sites of virion assembly.
In this report we test the hypothesis that HIV RNAs contain
specific RNA trafficking sequences. We identify two separate
A2RE-like sequences in the HIV-1 genome: A2RE-1 in the
gag gene and A2RE-2 in a region of overlap between the vpr
and tat genes. Both sequences bind to hnRNP A2 in vitro and
mediate hnRNP A2-dependent transport of HIV RNAs in
oligodendrocytes. The results suggest that intracellular traf-
ficking of HIV RNAs containing these sequences follows the
A2RE/hnRNP A2 pathway.
MATERIALS AND METHODS
RNA constructs. HIV-1 gag RNA (containing the complete 59 untranslated
region [UTR] and gag open reading frame [ORF] but truncated after the gag stop
codon) was transcribed from BamHI-linearized pKS-gag. To construct pKS-gag,
a fragment (1,855 bp) of HIV-1 proviral DNA from the tat activation (TAR)
region to just dowstream of the gag stop codon was PCR amplified using 59 XhoI
and 39 BamHI primers and inserted into pKSII. HIV-1 gag DKLM and HIV-1 gag
DA14 were transcribed from vectors constructed in a similar way, using frag-
ments of HIV-1 proviral DNA with deletions of the kissing loop (25) and
packaging signal (30), respectively. HIV-1 gag DA2RE-1 RNA was transcribed
from pKS-gag linearized with PstI, which cuts just upstream of A2RE-1. HIV-1
gag DUTR RNA was transcribed from pET21cgag DUTR. To construct
pET21cgag DUTR, HIV-1 gag was PCR amplified using 59 and 39 BamHI primers
and inserted into BamHI-digested pET21c (Novagen). HIV-1 gag hemagglutinin
(HA) RNA was transcribed from pKS-gag HA. To construct pKS-gag HA, PCR
primers (59-GGTACCTACCCCTACGACGTGCCCGACTACGACTATGTA
GACCGGTTCTATAAA-39 and 59-GTAGTCGGGCACGTCGTAGGGGTA
GGTACCTATGTCCAGAATGCTGGTAGGGCT-39) were designed to re-
place the A2RE-1 sequence with the HA tag. A second round of PCR using
flanking XhoI and BamHI primers was performed, and the resultant DNA was
cloned into pKSII to generate a gag chimera in which A2RE-1 was replaced with
an HA tag.
HIV-1 vpr RNA (containing the vpr ORF) was transcribed from PvuII-linear-
ized pET21c-vpr poly(A)1. This vector is based on pET21c-vpr (5), except that a
30-nt poly(A) tail was added by inserting a SacI/HindIII fragment from
sp64polyA1 (Gibco-BRL). HIV-1 vpr DA2RE-2 RNA was transcribed from
PvuII-linearized pET21c-1-88vpr, which was prepared using 59 XbaI and 39 SacI
primers to amplify truncated vpr lacking A2RE-2 for insertion into
pET21cPolyA1 (described above). HIV-2 vpr RNA was transcribed from an
HIV-2 transcription vector (pKS-vpr2) generated by PCR amplification of HIV-2
proviral DNA (HIV-2 ROD; accession number M15390) using 59 EcoRI and 39
SalI primers. The PCR fragment was inserted into pKSII to generate pKS-vpr2.
HIV-1 vpr A8G RNA was transcribed from pHIV vpr A8G. To construct pHIV
vpr A8G, PCR primers (59-GGG GCT GCA GCG CCG GCC ACC ATG GAA
CAA-39 and 59-GGG GTC TAG AGC GGA TCT ACT GGC CCC ATT TCT
TGC TCT CCT CTG TT-39) were used to create the A8G mutant vpr sequence,
which was digested with XbaI and PstI and cloned into XbaI-PstI-digested pHJ1
(23). A PstI-BsaWI fragment containing the A8G mutant vpr sequence fused in
frame to green fluorescent protein (GFP) was cloned into PstI-XmaI-digested
pBluescript plasmid, generating pHIV vpr A8G, which was linearized with SpeI
for in vitro transcription with T7 polymerase.
HIV-1 tat RNAs were transcribed from HindIII-linearized pKS-based tran-
scription vectors. A SalI-BamHI fragment from pGEM-3/Tatc (34) and a SacI/
BamHI fragment from pGEM-3/Ltatc (4) were cloned into pKSII to generate
pKS-tat and pKS-Ltat, respectively. HIV-1 tat DA2RE-2 RNA, a truncated ver-
sion of tat RNA lacking the 59 UTR, was transcribed from pKSTat. To construct
pKSTat, SalI- and BamHI-containing 59 and 39 primers were used to PCR
amplify tat cDNA from just upstream of the tat start codon to the BamHI site
downstream of the tat stop codon. The PCR product was recloned into pKSII to
generate pKS-TatDA2RE-2.
GFP RNA was transcribed from pNKT7 (23). GFP A2RE-1 and GFP A2RE-2
RNAs were transcribed from vectors constructed by inserting either A2RE-1 or
A2RE-2 into the SalI site of pNKT7.
All constructs were confirmed by restriction analysis and sequencing.
Cell culture and microinjection. Oligodendrocytes were prepared from new-
born mouse brain as described previously (1). Cells were plated on glass cover-
slips glued to the bottom of plastic culture dishes (MatTek Corp., Ashland,
Mass.). Fluorescent RNA, labeled with either Texas red- or AlexaFluor 488-
conjugated rUTP, was microinjected into cells as described previously (1). After
injection, the cells were returned to the tissue culture incubator for 15 to 30 min
to allow time for transport of the injected RNA from the perikaryon to the distal
processes and myelin compartment. The injected cells were examined by confo-
cal laser scanning microscopy and scored as either transport positive or transport
negative, using criteria described previously (2). Cells were treated with hnRNP
A2 sense (TCCGCGATGGAGAGAGAAAAG) or antisense (CTTTTCTCTC
TCCATCGCGGA) oligonucleotide to suppress hnRNP A2 expression, as de-
scribed previously (23). Cells were treated with nocodazole to disrupt microtu-
bules or with cytochalasin to disrupt actin microfilaments as described previously
(11).
Single granule ratiometric analysis. Single granule ratiometric analysis, per-
formed as described previously (6), was used to determine the ratios of different
RNAs in individual granules. Oligodendrocytes were coinjected with differen-
tially labeled gag (fluorescein) and vpr (Texas red) RNAs and imaged using
dual-channel confocal microscopy. Individual well-resolved granules were se-
lected, and fluorescent intensities in the red and green channels were integrated
over an area of nine pixels/granule. The ratio of the integrated intensity in the
red channel divided by the sum of the integrated intensities in both channels
provides a measure of the ratio of the two RNAs in each granule. For example,
a granule containing only vpr RNA with no gag RNA is detected only in the red
channel and therefore has a ratio of one, while a granule containing only gag
RNA with no vpr RNA is detected only in the green channel and has a ratio of
zero. Granules containing both gag and vpr RNAs are detected in both channels
and have intermediate ratios. The distribution of ratios for a population of
granules provides a measure of the variance in RNA distribution per granule in
the population.
hnRNP A2 binding assay. In vitro binding to RNA sequences immobilized on
paramagnetic beads was performed as described previously (21, 31).
RESULTS
HIV RNAs contain A2RE-like sequences. The NCBI nucle-
otide sequence database was searched for sequences similar to
the A2RE. Two A2RE-like sequences were identified in HIV-1
RNA: A2RE-1 in the gag gene and A2RE-2 in a region of
overlap between the vpr and tat genes (Fig. 1A). Full-length,
unspliced HIV genomic RNA, which is equivalent to gag
mRNA, contains both A2RE-1 and A2RE-2. Spliced HIV
RNAs encoding vpr, vif, and tat contain A2RE-2 only. Se-
quence polymorphism in the regions of the genome containing
A2RE-1 (Fig. 1B) and A2RE-2 (Fig. 1C) was analyzed in
HIV-1 sequences from the NCBI database. A2RE-1 is located
within the major homology region (MHR), a highly conserved
region of the gag ORF implicated in virion assembly (35, 37,
42). Sequence polymorphism in A2RE-1 is generally less than
in flanking regions of the gag gene except for positions 8 and
14, which have almost equivalent frequencies of A and G.
A2RE-2 is located in a region of overlap between the 39 end of
the vpr ORF and the 59 end of the tat ORF, adjacent to a
region identified as an exon splicing silencer (ESS2) (3, 40).
Sequence polymorphism in A2RE-2 is generally less than in
flanking regions of the vpr and tat genes. These results indicate
that A2RE-1 and A2RE-2 are relatively conserved sequences
in the HIV-1 genome.
To determine if A2RE-like sequences are conserved in other
retroviruses, the sequences of corresponding regions of the gag
and vpr genes from different retroviruses were compared.
Alignments of A2RE-like sequences in the gag genes of 14
different retroviruses and in the vpr genes of 3 different retro-
viruses are shown in Table 1. Conservation of A2RE-like se-
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quences in the gag gene ranged from 95% between HIV-1 and
HIV-2 to 50% between HIV-1 and feline leukemia virus
(FeLV). Conservation of A2RE-like sequences in the vpr gene
was approximately 50% between HIV-1 and HIV-2 or simian
immunodeficiency virus (SIV). These results indicate that
A2RE-like sequences are conserved among different retrovi-
ruses, suggesting that they are functionally important.
In all of the retroviral sequences examined, A2RE-like se-
quences in the gag ORF and the vpr ORF are translated in the
same reading frame. Furthermore, many of the nucleotide
substitutions in different retroviruses occur in the third posi-
tion of a codon and therefore do not affect the amino acid
sequence of the protein. The consensus amino acid sequences
encoded by A2RE-like sequences in the gag gene and vpr genes
FIG. 1. Identification of A2RE-like sequences in the HIV genome. (A) Diagram of the HIV-1 genome with the positions of the genes indicated.
A2RE-1 is located within the MHR in the gag gene and A2RE-2 is located in a region of overlap between the vpr and tat genes. (B) Sequence
polymorphism at each position in A2RE-1 and flanking regions in the gag gene. (C) Sequence polymorphism at each position in A2RE-2 and
flanking regions of the vpr and tat genes.
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are 42% identical and 71% similar (Table 1), raising the pos-
sibility that amino acid sequences encoded by A2RE-like se-
quences are important for Gag and Vpr protein function.
A2RE-like sequences mediate transport of HIV RNAs. To
determine if A2RE-like sequences in HIV mediate RNA
transport, fluorescently tagged RNAs containing these se-
quences were microinjected into oligodendrocytes, and the
intracellular distribution of the injected RNA was analyzed by
confocal laser scanning microscopy. Oligodendrocytes, instead
of a more common HIV host cell type, were used for the
transport assay because their extended and ramified morphol-
ogy facilitates the visualization of intracellular RNA trafficking
intermediates. Truncated HIV RNAs, instead of full-length
HIV RNAs, were used in order to measure the RNA traffick-
ing functions of ARE-1 and -2 independently of each other and
also to minimize confounding effects of sequence context and
potential non-A2RE trafficking signals in the HIV genome.
Cells were scored as transport positive if the injected RNA was
transported past the first branch point in at least one process.
Previous work has shown that cells injected with RNA con-
taining a functional A2RE (such as a full-length MBP mRNA)
are 70 to 80% transport positive, while cells injected with RNA
lacking a functional A2RE (such as GFP RNA, globin RNA,
or MBP RNA with the A2RE deleted) are less than 20%
transport positive. Thus, the dynamic range of the RNA trans-
port assay is from 20 to 70%. The structures of the RNAs
tested are diagrammed in Fig. 2A. The percentage of trans-
port-positive cells for each RNA is given in Fig. 2B. Images of
representative cells injected with each RNA are shown in Fig.
2C.
HIV-1 gag RNA, containing the gag 59 UTR and ORF in-
cluding A2RE-1 but lacking the 39 UTR, was transported in
.80% of injected cells, indicating that it contains a functional
RNA transport signal. Deletion of various regions from the 59
UTR of HIV-1 gag RNA (HIV-1 gag DKLM, HIV-1 gag DA14,
and HIV-1 gag D59 UTR) did not affect transport, indicating
that the 59 UTR does not contain RNA transport signals.
Deletion of A2RE-1 and downstream sequences from HIV-1
gag RNA (HIV-1 gag DA2RE-1) reduced transport to ,25%
of injected cells. Replacement of A2RE-1 with an HA tag
(HIV-1 gag HA) reduced transport to 5% of injected cells.
These results indicate that A2RE-1 is necessary for transport
of gag RNA.
HIV-1 vpr RNA, containing the vpr ORF, including A2RE-2
but lacking 59 and 39 UTRs, was transported in .75% of
injected cells, indicating that it contains a functional RNA
transport signal. Deletion of A2RE-2 from HIV-1 vpr RNA
(HIV-1 vpr DA2RE-2) reduced transport to ,25% of injected
cells, indicating that A2RE-2 is necessary for RNA transport.
A single point mutation (A8G) in A2RE-2 (HIV-1 vpr A8G)
abolished transport of vpr RNA (,25% transport positive).
Since this mutation is in the third position of a codon, it alters
the nucleotide sequence of vpr RNA without affecting the
amino acid sequence of Vpr protein, indicating that the RNA
trafficking function of A2RE-2 is nucleotide sequence depen-
dent rather than amino acid sequence dependent. HIV-2 vpr
RNA, which is 50% homologous to HIV-1 in the region of
A2RE-2, was transported in .75% of injected cells, indicating
that the RNA trafficking function of A2RE-2 is conserved
between HIV-1 and HIV-2.
TABLE 1. A2RE-like sequences in retroviral RNAs
Virusa Gene Positionb A2RE-like sequence
None MBP 1380 G C C A A G G A G C C A G A G A G C A U G
HIV-1 gag 1192 G A / C A A / G G A / C C A / A A A / G A A / C C C / U
HIV-2 gag 738 A - / - - - / - - - / - - - / - - - / - - - / - - - / -
SIV gag 586 - - / - - G / - - - / - - - / - - - / - - G / - - U / -
FIV gag 1474 - - / - - - / - - - / G - U / - - G / - - - / G A U / -
EIAV gag 833 - G / - - - / - - - / G - U / - - G / - - - / - - U / -
BIV gag 1187 A U / - - G / - - - / - - C / - - G / - - G / - - G / -
MPMV gag 1613 A - / - - - / - - - / - - C / G - U / - - G / - - A / -
HTLV-1 gag 1609 U C / - - - / - - C / - U G / G - G / - - G / - - U / -
GLV gag 1950 U G / - - G / - - - / - - G / G C - / - - - / - - - / C
Mo-MuLV gag 1429 C - / - - - / - - G / - - C / - - U / - - G / U - U / C
BLV gag 1364 U C / - - - / - - C / - - C / G C C / - - - / A G - / -
RSV gag 1566 U G / - - G / - - - / - - - / U C U / - - G / U - - / -
ALV gag 1790 C G / - - G / - - - / - - - / U C U / - - G / U - - / -
FeLV gag 1685 U G / - - - / - - G / A A - / G - A / - - - / A - G / C
Consensus amino acid R Q G P K E P
HIV-1 vpr 6157 G A / A A U / G G A / G C C / A G U / A G A / U C C / U
HIV-2 vpr 5855 U U / G - A / - - - / - - - / - - A / G A G / C U - / A
SIV vpr 6174 - - / - G - / - - - / U - A / G - A / - A U / G U - / A
Consensus amino acid R N G A R E S
a Abbreviations: avian leukosis virus (ALV), bovine immunodeficiency virus (BIV), bovine leukemia virus (BLV), equine infectious anemia virus (EIAV), feline
immunodeficiency virus (FIV), Gibbon leukemia virus (GLV), human T-cell leukemia virus type 1 (HTLV-1), Mason-Pfizer monkey virus (MPMV), Moloney murine
leukemia virus (Mo-MuLV), Rous sarcoma virus (RSV). The accession numbers for the gene sequences are as follows: MBP (NM 010777.1), HIV-1 gag (K02013),
HIV-2 gag (L33080), SIV gag (U10899), FIV gag (X57002), EIAV gag (AF170900), BIV gag (M32690), MPMV gag (AF033815), HTLV-1 gag (L03561), GLV gag
(U60065), Mo-MuLV gag (AF033811), BLV gag (K02120), RSV gag (AF033808), ALV gag (Z46390), FeLV gag (K01803) HIV-1 vpr (AF133821), HIV-2 vpr (X52223),
SIV vpr (AF131870).
b Position indicates the number of the first nucleotide in the A2RE-like sequence according to the numbering in the viral sequence from the corresponding accession
number.
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FIG. 2. Transport of HIV RNAs in oligodendrocytes. Fluorescent RNAs were microinjected into oligodendrocytes, and the subcellular
distribution of the injected RNA was visualized by confocal microscopy. (A) Structures of the various RNA constructs tested. ORFs are indicated
as open bars; UTRs are indicated as solid bars. The positions of A2RE-like sequences are indicated. (B) Percentage of transport-positive cells in
cells injected with each of the constructs in panel A. For each RNA tested, at least 50 cells were analyzed in at least three separate experiments.
(C) Distribution of injected RNA in representative cells for each construct. If the RNA was transported past the first branch point in the processes,
the cell was scored as transport positive. Scale bar, 10 mm.
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HIV-1 tat RNA, which also contains A2RE-2, was trans-
ported less efficiently (50% transport positive) than HIV-1 vpr
RNA (.75% transport positive), indicating that the transport
activity of A2RE-2 is sequence context dependent. Deletion of
A2RE-2 from HIV-1 tat RNA (HIV-1 tat DA2RE-2) abolished
transport of tat RNA (25% transport positive), indicating that
transport of tat RNA, albeit less efficient than that of vpr RNA,
is nevertheless A2RE-2 dependent. Inclusion of a portion (58
bp) of the tat 59 UTR (HIV-1 Ltat) abolished transport (,20%
transport positive), indicating that this 59 UTR sequence in-
terferes with the RNA transport function of A2RE-2.
A2RE-1 or A2RE-2 were inserted into GFP mRNA, which
by itself is retained in the perikaryon in oligodendrocytes. Both
GFP A2RE-1 RNA and GFP A2RE-2 RNA were transported
to the periphery (.75% transport positive in both cases), in-
dicating that either A2RE-1 or A2RE-2 is sufficient to mediate
RNA transport. Furthermore, since these sequences were in-
serted into the 39 UTR of GFP RNA, while they are located
within the ORF in gag RNA and vpr RNA, the RNA transport
functions of A2RE-1 and A2RE-2 are position independent.
A2RE-mediated transport of vpr and gag RNA is hnRNP A2
dependent. To determine if A2RE-like sequences from HIV-1
bind to hnRNP A2, the A2RE-1 and A2RE-2 sequences were
immobilized on paramagnetic beads and incubated with a pro-
tein extract from rat brain containing high levels of hnRNP A2.
The beads were isolated magnetically, and the bound protein
was analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) (Fig. 3). The spectrum of bound
proteins was identical for A2RE-1, A2RE-2, and A2RE from
MBP mRNA. In each case there were several minor bands and
a single predominant band with an apparent molecular mass of
36 kDa, identified previously as hnRNP A2 (21). These results
indicate that both A2RE-1 and A2RE-2 bind hnRNP A2 in
vitro. The in vitro protein binding assays were performed with
rat brain extract, while the in vivo RNA transport assays were
performed with mouse oligodendrocytes. However, since rat
and mouse hnRNP A2 proteins are .99% identical at the
amino acid level, the results of the protein binding experiments
suggest that hnRNP A2 is the cognate trans-acting factor for
A2RE-mediated RNA transport.
In the MBP A2RE a single point mutation (A8G) com-
pletely abolished hnRNP A2 binding in vitro and RNA trans-
port in vivo (31). An analogous A8G mutation was introduced
into A2RE-1 and A2RE-2 and tested for hnRNP A2 binding
by the paramagnetic bead binding assay (Fig. 3). The A8G
mutation in A2RE-1 decreased hnRNP A2 binding approxi-
mately twofold and in A2RE-2 abolished hnRNP A2 binding
completely, indicating that hnRNP A2 binding is nucleotide
sequence specific. Since the A8G mutation in A2RE-2 also
abolished transport of vpr RNA in vivo (Fig. 2), this suggests
that the RNA trafficking function of A2RE-2 requires hnRNP
A2 binding.
To determine if the transport of gag and vpr RNAs is hnRNP
A2 dependent, oligodendrocytes were treated with antisense
oligonucleotide to suppress hnRNP A2 expression prior to
analysis of RNA transport. Previous work demonstrated that
the treatment of oligodendrocytes with antisense oligonucleo-
tide reduced hnRNP A2 levels at least 10-fold and inhibited
the transport of A2RE-containing RNA, while the sense oli-
gonucleotide had little effect (23). The percent transport of
HIV-1 gag and vpr RNAs in sense- and antisense-treated cells
is shown in Fig. 4. In sense-treated cells, the transport of gag
and vpr RNA was unaffected (79 and 75% transport positive,
respectively). In antisense-treated cells, the transport of both
gag RNA and of vpr RNA was inhibited (30 and 20% transport
positive, respectively), indicating that transport of gag and vpr
RNA is hnRNP A2 dependent.
Transport of MBP RNA by the A2RE/hnRNP A2 RNA
trafficking pathway is microtubule dependent. To determine if
the transport of HIV-1 gag and vpr RNAs was microtubule
dependent, oligodendrocytes were treated with nocodazole, to
disrupt microtubules, or with cytochalasin, to disrupt micro-
FIG. 3. A2RE-1 and A2RE-2 bind to hnRNP A2 in vitro. Biotin-
conjugated oligoribonucleotides were immobilized on streptavidin-
coated paramagnetic beads and incubated with a protein extract from
rat brain. The beads were separated magnetically and washed exten-
sively, and the proteins bound to the beads were eluted and analyzed
by SDS-PAGE. The predominant protein, with a molecular mass of
approximately 36 kDa, has been previously identified as hnRNP A2.
The sequences of the oligoribonucleotides tested were as follows:
A2RE, GCCAAGGAGCCAGAGAGCAUG; A2RE A8G, GCCAA
GGGGCC; A2RE-1, GACAAGGACCAAAAGAACCCU; A2RE-1
A8G, GACAAGGGCCAAAAGAACCCU; A2RE-2, GAAAUGGA
GCCAGTAGAUCCUAG; A2RE-2 A8G, GAAAUGGGGCCAGTA
GAUCCUAG; and NSP, CAAGCACCGAACCGGCAACUG.
FIG. 4. Transport of HIV-1 gag and vpr RNA is hnRNP A2 depen-
dent and requires intact microtubules. Prior to microinjection oligo-
dendrocytes were treated with hnRNP A2 sense oligonucleotide as a
control, hnRNP A2 antisense oligonucleotide to reduce hnRNP A2
expression, nocodazole to disrupt microtubules, or cytochalasin to
disrupt microfilaments. The percentages of transport-positive cells for
HIV-1 gag and vpr RNA are shown.
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filaments, prior to microinjection. The percent transport of
HIV-1 gag and vpr RNAs in nocodazole- and cytochalasin-
treated cells is shown in Fig. 4. In nocodazole-treated cells, the
transport of both gag and vpr RNAs was inhibited (16 and 28%
transport positive, respectively), while in cytochalasin-treated
cells, the transport was unaffected (83 and 78% transport pos-
itive, respectively). These results indicate that transport of gag
and vpr RNA is microtubule dependent.
Coassembly of gag and vpr RNAs into granules. Assembly
into RNA granules is an integral step in RNA trafficking (6).
To determine if HIV gag and vpr RNAs are coassembled into
the same granules, differentially labeled gag (fluorescein) and
vpr (Texas red) RNAs were coinjected into oligodendrocytes
and analyzed by dual-channel confocal microscopy (Fig. 5, top
panel). In the merged image, virtually all of the granules ap-
peared yellow, indicating colocalization of gag (green) and vpr
(red) RNAs. The relative distribution of gag and vpr RNAs in
individual granules was analyzed by single granule ratiometric
analysis (Fig. 5, bottom panel). The histogram shows that most
granules contained both gag and vpr RNA molecules. Since
both gag and vpr RNAs follow the A2RE/hnRNP A2 trafficking
pathway, this suggests that RNAs with similar trafficking path-
ways are coassembled into the same granules.
DISCUSSION
Two cis-acting RNA trafficking sequences, A2RE-1 and
A2RE-2, have been identified in the HIV genome. Both se-
quences bind to the trans-acting factor hnRNP A2 in vitro and
mediate hnRNP A2-dependent transport of HIV RNAs in
oligodendrocytes in vivo. Since A2RE-like sequences are
found in a variety of different RNAs (2) and since hnRNP A2
is expressed in many different cell types (22), it is likely that the
A2RE/hnRNP A2 pathway is a constitutive RNA trafficking
pathway in most cells. Therefore, A2RE-containing HIV RNAs
may follow the A2RE/hnRNP A2 trafficking pathway in HIV
host cells.
In HIV-infected cells, unspliced 9-kb HIV-1 RNA, which
serves as both genomic RNA and gag mRNA, contains both
A2RE-1 and A2RE-2, while singly spliced vpr and vif mRNAs
and multiply spliced tat mRNA contain A2RE-2 alone. Most of
the HIV RNAs analyzed in this work lacked the 59 and/or 39
UTRs found in HIV RNAs expressed in infected cells. If the
missing regions contain sequences that modulate A2RE-1 or
A2RE-2 function or non-A2RE RNA trafficking signals, the
trafficking pathways for HIV RNAs in infected cells might be
different from the trafficking pathways reported here for trun-
cated HIV RNAs in oligodendrocytes.
The sequence context does affect the trafficking function of
A2RE-2 in tat RNA which was transported less efficiently than
vpr RNA. One possibility is that the RNA trafficking function
of A2RE-2 is position dependent. A2RE-2 is located near the
39 end of the ORF in vpr RNA and near the 59 end of the ORF
in tat RNA, which may affect its function. This is unlikely
because the A2RE in MBP RNA is located in the 39 UTR,
whereas A2RE-2 in vpr RNA is located within the ORF and
also functions when inserted into the 39 UTR of GFP RNA. A
second possibility is that the tat ORF and/or 59 UTR contain
perikaryon retention signals that are epistatic to the transport
function of A2RE-2, causing retention of tat RNA in the
perikaryon, despite the presence of A2RE-2. This is also un-
likely because the 59 UTR sequences that are present in tat
RNA, which is not transported efficiently, are also present in
gag RNA, which is transported efficiently. A third possibility is
that the tat ORF and/or 59 UTR contain sequences that inter-
fere with the RNA transport function of A2RE-2. RNA trans-
port requires binding of the trans-acting ligand hnRNP A2 to
A2RE. RNA secondary structure in the region of the A2RE
could interfere with hnRNP A2 binding, thereby reducing
RNA transport efficiency. The potential secondary structure in
the A2RE-2 region of vpr and tat RNA was examined using the
MFOLD program in the GCG Sequence Analysis Package
(University of Wisconsin) (data not shown). In vpr RNA no
stable secondary structure that might interfere with hnRNP A2
binding to A2RE-2 was predicted. In tat RNA, on the other
hand, the A2RE-2 region was predicted to base pair with a
downstream region of the ORF to form a stable stem-loop
structure that could potentially interfere with hnRNP A2 bind-
ing and reduce the transport efficiency of tat RNA compared to
vpr RNA. Furthermore, a complicated secondary structure
consisting of several stem-loops has been predicted in the 59
UTR of tat RNA (30). Juxtaposition of this 59 UTR secondary
structure with A2RE-2 in the tat ORF could reduce hnRNP A2
binding, thereby inhibiting transport of tat RNA. Differences in
RNA secondary structure resulting in differences in hnRNP A2
binding to A2RE-2 could explain the differential transport
efficiencies for vpr and tat RNAs.
A single base change at the A8 position in A2RE-1 or -2 was
sufficient to inhibit hnRNP A2 binding and, in the case of
A2RE-2, to abrogate vpr RNA transport. Sequence polymor-
phism at the A8 position in A2RE-1 and A2RE-2 was analyzed
in HIV-1 sequences from the NCBI database. The A8G mu-
tation in A2RE-1, which reduced but did not abolish hnRNP
A2 binding, was present in ca. 40% of HIV-1 isolates (Fig. 1),
indicating that it represents a frequently occurring sequence
polymorphism in the HIV-1 genome. This suggests that this
mutation does not have significant deleterious phenotypic con-
sequences for the virus, implying that the residual hnRNP A2
binding observed with this mutation is sufficient for A2RE-1
function. On the other hand, the A8G mutation in A2RE-2,
which abolished hnRNP A2 binding and abrogated vpr RNA
transport, was found in only three HIV-1 sequences (all from
Australia) out of 1,074 different HIV-1 sequences in the data-
base. One sequence (accession number U61889) was isolated
from a long-term nonprogressor (39), a second sequence with
several variants characterized by high replication in macro-
phages (accession numbers AF133405, AF133410, AF133415,
and AF133420) was isolated from an individual with cate-
gory IV AIDS (32), and a third sequence (accession number
U41708) was isolated from an intravenous drug user (19).
Since each of these isolates carries additional sequence poly-
morphisms in other regions of the genome, their phenotypes
are not necessarily attributable to the A8G mutation in
A2RE-2. Nevertheless, the infrequent occurrence of the A8G
mutation in the HIV genome implies that hnRNP A2 binding
is important for A2RE-2 function.
Identification of A2RE-like RNA trafficking signals in the
HIV genome suggests that in infected cells HIV RNAs follow
the constitutive A2RE/hnRNP A2 RNA trafficking pathway, as
outlined in Fig. 6. According to this model, hnRNP A2 binds to
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FIG. 5. Colocalization of HIV-1 gag and vpr RNAs. Oligodendrocytes were coinjected with fluorescein-labeled gag RNA and Texas red-labeled
vpr RNA. The distributions of the two RNAs were visualized by dual-channel confocal microscopy. (A) Distribution of gag RNA in the green
channel and vpr RNA in the red channel. The overlap of red and green appears yellow. The ratio of gag and vpr RNA in each granule was
determined by single granule ratiometric analysis. (B) The distribution of ratios for a population of 748 granules is shown as a histogram. The mean
is 0.48, and the variance is 0.0085, from which a sample size of 29 RNA molecules/granule was calculated.
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A2RE-containing HIV RNAs in the nucleus and remains as-
sociated throughout subsequent trafficking. Although not an-
alyzed in this study, nuclear processing of HIV RNAs may be
affected by hnRNP A2 and A2RE determinants. Exon splicing
silencing by cis-acting ESS sequences in viral and cellular
RNAs is mediated by hnRNP A2 (10, 16), and A2RE-2 is
immediately adjacent to ESS2 in HIV RNA. A recent model
describing coupled HIV-1 RNA splicing and RNA transport
(27) proposes that several RNA-binding proteins are involved
in premature spliceosome dissolution on unspliced and singly
spliced HIV-1 transcripts destined for Rev-mediated nuclear
export. Splicing and transport of HIV RNAs could be coupled
via A2RE and hnRNP A2 determinants.
Nuclear export of unspliced and singly spliced HIV tran-
scripts is mediated by the cis-acting RRE (28), which is recog-
nized by the trans-acting viral Rev protein (36). In the cytosol,
RRE-containing RNAs are either translated on polyribosomes
or, in the case of full-length, unspliced HIV RNA, encapsi-
dated into progeny virions. There are certain parallels between
the previously characterized Rev/RRE pathway and the hnRNP
A2/A2RE pathway described here. Both Rev and hnRNP A2
bind to their respective target RNAs in the nucleus, remain
associated during export through the nuclear pore, and en-
hance translation in the cytoplasm (9, 23, 43). Since unspliced
and singly spliced HIV RNAs contain both RRE and A2RE-1
and/or A2RE-2, trafficking of these RNAs may be mediated by
the combined actions of Rev and hnRNP A2. The Rev/RRE
pathway determines which HIV RNAs are exported from the
nucleus. The hnRNP A2/A2RE pathway may determine where
these RNAs are transported in the cytoplasm.
In the perikaryon, HIV RNAs, containing either A2RE-1 or
A2RE-2, are coassembled into granules for subsequent traf-
ficking. Coassembly into the same granules ensures that
A2RE-containing RNAs are cotransported and cotranslated in
the same region of the cell. The HIV RNAs analyzed here each
contained a single A2RE-like sequence. In HIV-infected cells,
unspliced gag RNA contains two A2RE-like sequences, A2RE-1
and A2RE-2, while singly spliced vpr and vif RNAs contain only
A2RE-2. If the stoichiometry of assembly into granules is deter-
mined by the number of A2RE-like sequences in each RNA, then
unspliced gag mRNA may be assembled into granules more effi-
ciently than singly spliced vpr and vif RNAs. This could result in
proportionately higher levels of gag RNA compared to vpr and vif
RNAs in each granule, leading to higher levels of Gag protein
expression compared to the Vpr and Vif proteins. The stoichio-
metries of different viral RNAs in each granule could provide a
mechanism for coordinating the expression of the corresponding
viral proteins.
The total number of RNA molecules per granule can be
calculated from the distribution of ratios shown in Fig. 5. If the
number of RNA molecules in each granule corresponds to a
sample of size N, from a binomial population of vpr (red) and
gag (green) RNA molecules, then the ratio for each granule
corresponds to the mean for that sample, and the distribution
of ratios represents the sampling distribution of the means for
samples of size N. According to the central limit theorem, as
the sample size increases, the distribution of the sample means
approaches normality. The variance, V, in the distribution of
ratios is inversely proportional to the sample size, N, according
to the following equation: V 5 RG/N, where R is the mean
proportion of red molecules (vpr RNA) and G is the mean
proportion of green molecules (gag RNA) in the population.
The calculated variance for the distribution of ratios of vpr
RNA and gag RNA was 0.0085. This corresponds to an esti-
mated mean sample size of 29, which means that each granule
contains approximately 29 RNA molecules.
This estimate is based on several assumptions. One assump-
tion is that the observed variance is entirely statistical with no
experimental component. Experimental factors that could po-
tentially contribute to the variance include bias in granule
selection, misregistration between the red and green channels
due to a chromatic aberration in the optical path, and differ-
ences in signal-to-noise, sensitivity, or nongranule background
fluorescence values between the two channels. These experi-
FIG. 6. Model for hnRNP A2/A2RE-mediated intracellular trafficking of HIV RNAs. gag RNA (green squiggles) and vpr RNA (red squiggles)
both contain A2RE-like sequences that bind to hnRNP A2 (blue spheres) in the nucleus. In the cytoplasm, multiple gag and vpr RNA molecules,
with hnRNP A2 associated, coassemble into granules (orange spheres). Granules containing both gag and vpr RNA are transported to the plus ends
of microtubules in the periphery of the cell where the Gag protein (green spheres) and the Vpr protein (red spheres) are cotranslated. Gag and
Vpr proteins coassemble with HIV genomic RNA (green squiggles) into virions at the plasma membrane.
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mental factors could either increase or decrease the observed
variance, leading to underestimation or overestimation of the
actual number of RNA molecules per granule. A second as-
sumption is that the number of RNA molecules is the same for
all granules. Granules with lower intensity will contribute dis-
proportionately more to the observed variance in the popula-
tion, leading to underestimation of the mean number of RNA
molecules per granule, while granules with higher intensity will
contribute less to the variance, leading to overestimation. A
third assumption is that each granule contains exclusively gag
and vpr RNAs. Oligodendrocytes are known to express several
endogenous A2RE-containing RNAs, such as MBP mRNA
and MOBP mRNA (2), that may coassemble into the same
granules as gag and vpr RNAs. Since endogenous A2RE-con-
taining RNAs are unlabeled, the actual number of RNA mol-
ecules per granule may be greater than the estimate made from
the ratios of labeled gag and vpr RNAs. Since these assump-
tions are difficult to test directly, there is some uncertainty in
the estimated number of RNA molecules per granule.
Granules containing HIV RNAs with either A2RE-1 and/or
-2 are transported toward the plus ends of microtubules in the
periphery of the cell, where translation is activated and virion
assembly occurs. A2RE-mediated transport of HIV RNAs may
affect localization of the encoded proteins. Tat RNA, which is
not transported, encodes a protein destined for the nucleus,
while gag and vpr RNAs, which are transported, encode pro-
teins that are incorporated into virions. Vif RNA, which was
not tested in the transport assay, also contains A2RE-2, and
Vif protein colocalizes with Gag protein in infected cells (41).
A2RE-mediated RNA transport may steer the expression of
Gag and Vpr (and possibly Vif) proteins to sites of virion
assembly, while retention of tat RNA in the cell body may
restrict expression of Tat protein to the perikaryon.
Translation of A2RE-containing RNA is activated through
an hnRNP A2-dependent mechanism. In other systems trans-
lation is repressed while the RNA is in transit, preventing
ectopic expression of the encoded proteins. If translation of
HIV gag and vpr RNA is repressed until the RNA is localized
to the periphery of the cell, this would restrict the expression of
Gag and Vpr proteins to the periphery of the cell, close to the
plasma membrane where virion assembly occurs. Both Gag
and Vpr proteins contain strong nuclear import signals, which
might cause them to be imported into the nucleus if the pro-
teins were expressed at high levels in the perikaryon. Restrict-
ing the translation of gag and vpr RNAs to the cell periphery
could provide a mechanism to effectively steer expression of
Gag and Vpr proteins away from the nucleus and toward the
sites of virion assembly.
HIV genomic RNA contains both A2RE-1 and -2 and there-
fore presumably binds to hnRNP A2 and is assembled into
granules for transport to sites of virion assembly. However,
hnRNP A2 is not detected in mature virus particles (unpub-
lished observations). This means that genomic RNA molecules
must dissociate from hnRNP A2 and be released from granules
prior to encapsidation. The mechanism(s) for the dissociation
of HIV genomic RNA from hnRNP A2 and release from
granules is not known.
In summary, the HIV genome contains specific sequences
that can mediate intracellular trafficking of HIV RNAs
through the A2RE/hnRNP A2 RNA pathway. Intracellular
RNA trafficking could potentially affect various aspects of HIV
gene expression including splicing, nuclear export, cytoplasmic
transport, translation, and virion assembly. The A2RE/hnRNP
A2 RNA pathway may play an important role in the HIV life
cycle.
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